Literature DB >> 17038439

Hemodynamic analysis of Hyrtl anastomosis in human placenta.

Zoya Gordon1, Osnat Eytan, Ariel J Jaffa, David Elad.   

Abstract

The Hyrtl anastomosis is a common connection between the umbilical arteries near the cord insertion in most human placentas. It has been speculated that it equalizes the blood pressure between the territories supplied by the umbilical arteries. However, its functional role in the regulation and distribution of fetal blood flow to the placenta has not yet been explored. A computational model has been developed for quantitative analysis of hemodynamic characteristic of the Hyrtl anastomosis in cases of discordant blood flow in the umbilical arteries. Simulations were performed for cases of either increased placental resistance at the downstream end or reduced arterial blood flow due to some pathologies upstream of one of the arteries. The results indicate that when placental territories of one artery impose increased resistance to fetal blood flow, the Hyrtl anastomosis redistributes the blood flow into the second artery to reduce the large pressure gradients that are developed in the affected artery. When one of the arteries conducts a smaller blood flow into the placenta and a relatively smaller pressure gradient is developed, the Hyrtl anastomosis rebuilds the pressure gradients in the affected artery and redistributes blood flow from the unaffected artery to the affected one to improve placental perfusion. In conclusion, the Hyrtl anastomosis plays the role of either a safety valve or a pressure stabilizer between the umbilical arteries at the placental insertion.

Entities:  

Mesh:

Year:  2006        PMID: 17038439     DOI: 10.1152/ajpregu.00410.2006

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

Review 1.  Sonographic Assessment of the Umbilical Cord.

Authors:  S Bosselmann; G Mielke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-08       Impact factor: 2.915

2.  Structure-function relationships in the feto-placental circulation from in silico interpretation of micro-CT vascular structures.

Authors:  Monika Byrne; Rosalind Aughwane; Joanna L James; J Ciaran Hutchinson; Owen J Arthurs; Neil J Sebire; Sebastien Ourselin; Anna L David; Andrew Melbourne; Alys R Clark
Journal:  J Theor Biol       Date:  2021-02-17       Impact factor: 2.405

Review 3.  The development, structure and blood flow within the umbilical cord with particular reference to the venous system.

Authors:  Jacqueline Spurway; Patricia Logan; Sokcheon Pak
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

4.  Whole organ vascular casting and microCT examination of the human placental vascular tree reveals novel alterations associated with pregnancy disease.

Authors:  Toluwalope O Junaid; Robert S Bradley; Rohan M Lewis; John D Aplin; Edward D Johnstone
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

5.  Intrauterine Transfusion Complicated by Umbilical Artery Thrombosis.

Authors:  Roopali V Donepudi; Kenneth J Moise
Journal:  Case Rep Obstet Gynecol       Date:  2019-02-20

6.  The relationship among the progression of inflammation in umbilical cord, fetal inflammatory response, early-onset neonatal sepsis, and chorioamnionitis.

Authors:  Jeong-Won Oh; Chan-Wook Park; Kyung Chul Moon; Joong Shin Park; Jong Kwan Jun
Journal:  PLoS One       Date:  2019-11-19       Impact factor: 3.240

7.  The human placenta as a model for training and research in mechanical thrombectomy: Clarifications and use of the chorionic plate veins.

Authors:  Julien Burel; Jonathan Cornacchini; Matthieu Garnier; Sophie Patrier; Albane Guigné; Emmanuel Gerardin; Chrysanthi Papagiannaki; Nader Sourour; Eimad Shotar; Kévin Premat; Claire Laporte; Frédéric Clarençon
Journal:  Front Neurol       Date:  2022-09-20       Impact factor: 4.086

Review 8.  Advances in Human Placental Biomechanics.

Authors:  R Plitman Mayo
Journal:  Comput Struct Biotechnol J       Date:  2018-08-24       Impact factor: 7.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.